Press Releases

Onkos Surgical® raises $15 million in series c funding

Funds will accelerate innovation, expand commercial presence, and drive manufacturing improvements in surgical solutions for musculoskeletal oncology and complex orthopaedicsPARSIPPANY, N.J., Sept. 1, 2021— Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has raised $15 million in Series C funding...
Learn More

Onkos Surgical® announces FDA 510(k) clearance of its BioGrip® modular porous collars, a first-of-its-kind solution to help address implant loosening in orthopaedic oncology and complex revision surgery

The new offering, available as part of the ELEOS™ Limb Salvage System, is designed to help support bone ingrowth in musculoskeletal oncology and complex orthopaedic limb salvage cases with a novel 3D-printed porous designPARSIPPANY, N.J., June 22, 2021— Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex...
Learn More

Onkos Surgical® continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS Proximal Tibia with BioGrip technology

PARSIPPANY, N.J., December 21, 2020 –  Onkos Surgical, Inc., an innovator in the field of musculoskeletal oncology and personalized orthopaedics, continues to deliver on its promise of commercializing innovative solutions with the launch of the new ELEOS Proximal Tibia with BioGrip technology. The product, used in complex tumor and orthopaedic...
Learn More

Business Update Regarding COVID-19

March 27, 2020 – We recognize that our customers, patients, caregivers, and partners have a great deal of information coming from all directions during this rapidly changing time. This memorandum is a brief update regarding what Onkos Surgical is doing to ensure business continuity. First, on behalf of everyone at Onkos,...
Learn More